Nasdaq · Biotech stocks database
TIL (Instil Bio Inc.) stock: $6.83, $46.3M market cap, $69.7M cash, -$23.4M EV, $56.8M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
We are a biotechnology company focused on identifying and advancing innovative therapeutic opportunities. In January 2026 we announced our wholly owned subsidiary, Axion Bio, Inc., or Axion Bio, was discontinuing development of our former lead product candidate, AXN-2510, a bispecific antibody targeting both programmed death-ligand 1 and the family of vascular endothelial growth factors in solid tumor cancers.
Source: 10-K FY2025 via SEC EDGAR
| Cash | $69.7M |
|---|---|
| Debt | $0.0M |
| Net cash | $69.7M |
| Enterprise value | -$23.4M |
| Basic shares | 6.8M shares |
| Fully diluted shares | 8.3M shares |
| Fully diluted market cap | $56.8M |
| Cash per share | $10.27 |
| Quarterly burn | $4.6M |
| Cash runway | 15.0 quarters |
Cash figures as of 2026-06-30. Database snapshot: 2026-11-07.
Cap table as of 2026-08-11.
Loading TIL daily closes…